ยาเคมีบำบัดสูตร Trastuzumab - Chulacancer รังสีรักษาและมะเร็งวิทยา

Trastuzumab exerts an antitumour activity and is used in the treatment of HER2-positive breast cancer HER2 protein overexpression is observed in 20%-30% of

Trastuzumab injection products may cause serious or life-threatening reactions that may occur while the medication is being given or up to 24

trastuzumab A study of more than 4000 patients, published in 2014, showed that adding trastuzumab to chemotherapy led to a 37% relative improvement in

trastuzumab Descriptions Trastuzumab injection is used to treat HER2-overexpressing new or metastatic breast cancer It can be